azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['toci', 'aza ', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'myeloid', 'novo ', 'imab ']
#ash22 #leusm daver: pivek dose escalation and ven dose escalation explored (rp2d 14days ven). no tls or vod. suitable toxicity profile. orr 45%, 13% cr, a lot of mlfs. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)